Cohort Dashboard
GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.
Total Global Data
Last Updated: April 23, 2024 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova
Molecular Testing of Polish PD Patients
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Mount Sinai Cohort
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Movement Disorders Biobanc
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
MPBC
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Multicentric Retrospective and Prospective PD Database
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
NET-PD
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
New Zealand Parkinson's Environment and Genes Study
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Ancestry Breakdown for Samples Completed
ShowNew Zealand Parkinson's Programme
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
Ancestry Breakdown for Samples Completed
ShowNGC
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
NGIPDO - Neurogenomics and Informatics Center - Parkinson's Disease Deep Molecular Profiling
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
